Publications by authors named "Dupont Guerry"

Claim this Profile
O
Oncology: What You May Have Missed in 2023.
Courtney H Coschi, Lorin Dodbiba, DuPont Guerry

Ann Intern Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Miscoding of Melanoma Thickness in SEER: Research and Clinical Implications.
Phyllis A Gimotty, Ronald Shore, Nancy L Lozon, Jeanne Whitlock, Sidan He, DuPont Guerry

J Invest Dermatol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity.
Edmund K Bartlett, Madalyn G Peters, Anne Blair, Mark S Etherington, David E Elder, DuPont Guerry

Ann Surg Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphatic invasion as a prognostic biomarker in primary cutaneous melanoma.
Xiaowei Xu, Phyllis A Gimotty, Dupont Guerry, Giorgos Karakousis, David E Elder

Methods Mol Biol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy.
Edmund K Bartlett, Meera Gupta, Jashodeep Datta, Phyllis A Gimotty, DuPont Guerry

Ann Surg Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy.
Edmund K Bartlett, Phyllis A Gimotty, Andrew J Sinnamon, Heather Wachtel, Robert E Roses, DuPont Guerry

Ann Surg Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local immune response predicts survival in patients with thick (t4) melanomas.
Jessica A Cintolo, Phyllis Gimotty, Anne Blair, Dupont Guerry, David E Elder

Ann Surg Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma.
Xiaowei Xu, Lianjun Chen, DuPont Guerry, Peter R Dawson, Wei-ting Hwang

Clin Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunbeds and sunlamps: who used them and their risk for melanoma.
Thomas R Fears, Richard W Sagebiel, Allan Halpern, David E Elder, Elizabeth A Holly, Dupont Guerry

Pigment Cell Melanoma Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High lymphatic vessel density and lymphatic invasion underlie the adverse prognostic effect of radial growth phase regression in melanoma.
Sook Jung Yun, Phyllis A Gimotty, Wei-Ting Hwang, Peter Dawson, Patricia Van Belle, DuPont Guerry

Am J Surg Pathol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostication in thin cutaneous melanomas.
Phyllis A Gimotty, DuPont Guerry

Arch Pathol Lab Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
Peter A Kanetsky, Saarene Panossian, David E Elder, DuPont Guerry, Michael E Ming

Cancer· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics associated with early and late melanoma metastases.
Jeremy A Brauer, Cooper C Wriston, Andrea B Troxel, Rosalie Elenitsas, Daniel B Shin, Dupont Guerry

Cancer· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic effect of sentinel lymph node biopsy in melanoma remains an open question.
Phyllis A Gimotty, Frank Yoon, Rachel Hammond, Paul Rosenbaum, DuPont Guerry

J Clin Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis.
Xiaowei Xu, Phyllis A Gimotty, Dupont Guerry, Giorgos Karakousis, Patricia Van Belle

Hum Pathol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients.
Phyllis A Gimotty, DuPont Guerry, Keith Flaherty

J Clin Oncol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eruptive disseminated Spitz nevi.
Ross M Levy, Michael E Ming, Michael Shapiro, Margaret Tucker, Dupont Guerry

J Am Acad Dermatol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.
Giorgos C Karakousis, Phyllis A Gimotty, Brian J Czerniecki, David E Elder, Rosalie Elenitsas, DuPont Guerry

Ann Surg Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.
Rolf K Swoboda, Rajasekharan Somasundaram, Laura Caputo, Elizabeth M Ochoa, Phyllis A Gimotty, DuPont Guerry

Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproductive risk factors for cutaneous melanoma in women: a case-control study.
C Suzanne Lea, Elizabeth A Holly, Patricia Hartge, Jennifer S Lee, Dupont Guerry

Am J Epidemiol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
Phyllis A Gimotty, David E Elder, Douglas L Fraker, Jeffrey Botbyl, Kimberly Sellers, DuPont Guerry

J Clin Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
Laura L Kruper, Francis R Spitz, Brian J Czerniecki, Douglas L Fraker, Anne Blackwood-Chirchir, Dupont Guerry

Cancer· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying individuals at high risk of melanoma: a practical predictor of absolute risk.
Thomas R Fears, DuPont Guerry, Ruth M Pfeiffer, Richard W Sagebiel, David E Elder

J Clin Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation of normal skin and melanoma using high resolution hyperspectral imaging.
David T Dicker, Jeremy Lerner, Pat Van Belle, Stephen F Barth, Dupont Guerry

Cancer Biol Ther· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients.
Rajasekharan Somasundaram, Rolf Swoboda, Laura Caputo, Laszlo Otvos, Barbara Weber, DuPont Guerry

Cancer Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis